Management’s guidance for the full year (FY 23-24) :
Business Growth – 12 to 15%
NIM – Above 4%
ROA – 1.75 to 2%
ROE – Above 15%
GNPA – Less than 2%
NNPA – Less than 1%
Cost to Income – Around 44%
Slippage ratio – Less than 1%
Posts tagged Value Pickr
Tamilnad Mercantile Bank Ltd (TMB Ltd) – An undervalued pvt. sector bank? (02-11-2023)
Edelweiss Financial Services (02-11-2023)
could you please explain the rational behind the debt in Nuvama , why it increased where as peer Anand Rathi is debt free. I can understand Motila Oswal and all have lending business, where these debts are used for Nuvama.
Embassy REIT: Is this “Blackstone” promoted REIT is real diamond? (02-11-2023)
@Shrish_Vaze
Appreciate bringing out valid point. Find enlcosed Q1FY24 Transcript leasing area guidenace.
In Q2FY24 Transcript, leasing are guideance get revised as under:
So your point is valid that actually after accounting for 0.6 mn sq ft early renewal, guideance shall have been 6.6 mn sq ft. However, this are projections and 0.1 mn sq ft on 6.0 mn st ft account for less than 2% of total renewal area. In projection, which are volatile and uncertain, I would not consider this as singificant negative. In fact, the tenant of pedigree of IBM moved ahead and renewed early for 0.6 mn sq ft area, does give sense of optimism about lease rental in Bengaluru market. One may called this as my ownership bias, to see everything with positive perspective and ignoring adverse news totally.
Thanks once again to bring out valid concern. However, in my personal view, it is business as usual and not majorly negative. My undetstanding may be wrong.
Natco Pharma: Focusing On Complex Products (02-11-2023)
Hi James, the Freedom of Information Act allows entities/people to ask for information from USFDA and obligates them to respond. All together 3 different entities had requesed the details of Form 483 issued to Natco Pharma Kothur unit from USFDA. They are bloomberg news, east lane capital and education for all. The USFDA had closed/replied to their requests on 31.10.2023. So on 1st november one or more of these entities who got access to the information may have disclosed it to the business news channels or social media. Hope this clears your query.
p.s. I am not an expert in anything. just plain google search will lead you there.
Natco Pharma: Focusing On Complex Products (02-11-2023)
You can access the 483 from the FDA website, the latest audit 483 have to be requested to the FDA separately which can be accessed for a fee.
Natco Pharma: Focusing On Complex Products (02-11-2023)
I could not find anything on this from BSE/NSE filings. Can someone cite the source other than media reports ? How could one refer this observations. Anyone expert in FDA matters , please hell.
The filing today about zero observations on corporate office at their firm’s pharmacovigilance department.
Mudit’s Portfolio (Passively Active) (02-11-2023)
I already hold ICICI bank. And since already including HDFC bank, i will be having 3 banks and 2 NBfCs hence no kotak. I used to hold it earlier, but not now. Overall Financial sector also should not cross a particular limit.
Mudit’s Portfolio (Passively Active) (02-11-2023)
Any SWOT done with Kotak/ICICI before buying HDFC. Also, why not other Large Caps outside of banking such as PowerGrid or ITC?HUL if stability is only criteria.
Macfos Limited- A niche E-commerce Company (02-11-2023)
The company has come out with an investor presentation. Three important data-point has been shared.
SKU has grown to 16,220, a very positive development. Every increase in SKU increases the competitive strength of the company.
The investor presentation is as follows;
581e71a0-012f-4a5b-8d2f-ebfdfae1b67a.pdf (1.6 MB)